Curcumin

Curcumin is a bioactive polyphenolic compound and the primary curcuminoid found in the rhizomes of the turmeric plant (Curcuma longa). While frequently discussed in therapeutic research, it is technically a phytochemical ligand or chemical compound rather than a biological target such as a protein, receptor, or enzyme [4, 12]. It is highly pleiotropic, meaning it interacts with and modulates an exceptionally wide range of molecular targets including transcription factors (e.g., NF-κB, Nrf2), enzymes (e.g., COX-2, LOX), and various signaling kinases [1, 17]. Curcumin is investigated for its anti-inflammatory, antioxidant, and anticancer properties, demonstrating potential in treating conditions such as osteoarthritis, metabolic syndrome, and various malignancies in preclinical models [5, 13, 14, 15]. However, its development as a clinical pharmaceutical is severely limited by poor water solubility, rapid systemic metabolism, and very low bioavailability [12, 14]. Furthermore, curcumin is often identified as a 'pan-assay interference compound' (PAINS) due to its chemical instability and potential for non-specific interactions in drug discovery assays [12, 17].

Other names

DiferuloylmethaneNatural Yellow 3CI 75300E100

Curcumin acts as a multi-target modulator that inhibits pro-inflammatory signaling pathways, primarily by blocking the activation of nuclear factor-kappa B (NF-κB) and inhibiting enzymes such as cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) [1, 5]. It also exerts antioxidant effects by activating the Nrf2 signaling pathway, which induces the expression of phase II antioxidant enzymes [2, 14].